GotoPER - Physicians' Education Resource
Back to Home
Video

Medical Crossfire®: The Who, When, and How of TROP2-Targeting ADCs, ICIs, and PARP inhibition in Triple-Negative Breast Cancer

Create AccountAlready Registered? Login Here

Release Date

December 19, 2025

Expiration Date

January 17, 2026

Credits

2.0 CME, NCPD

Specialties

Breast Cancer, General Oncology+3 more

Release Date: December 19, 2025

Expiration Date: January 16, 2026

Activity Overview

This educational activity is an archive of the live presentation held on Wednesday, December 10, 2025.

For more information about this educational activity, the faculty, and disclosures, please click here.

Target Audience

This educational activity is directed toward medical oncologists, advanced practice providers, nurses, and other health care professionals involved in the treatment and management of triple-negative breast cancer (TNBC).

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Apply actionable biomarkers alongside tumor and patient-specific factors to guide treatment decisions in early and advanced triple-negative breast cancer (TNBC)
  • Develop personalized treatment strategies informed by current and emerging trial evidence for early and advanced TNBC
  • Implement approaches to proactively mitigate, monitor, and manage treatment-related adverse events
  • Evaluate ongoing clinical trials in early and advanced TNBC investigating novel agents and combination strategies
Medical Crossfire®: The Who, When, and How of TROP2-Targeting ADCs, ICIs, and PARP inhibition in Triple-Negative Breast Cancer

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours.


Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca; BioNTech; Daiichi Sankyo, Inc; and Merck Sharp & Dohme Corp.

Related Content

View All

Course

Medical Crossfire®: The Who, When, and How of TROP2-Targeting ADCs, ICIs, and PARP inhibition in Triple-Negative Breast Cancer

Create Account